You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
By James Dunn
Shares in home-grown biotech star CSL shot above $50 on an upgraded profit outlook. Is it too late to buy? James Dunn analyses CSL's outlook.
Andrew Bloore: Seven tips on Transition to Retirement pensions
By Paul Rickard
Bonds form an important part of a diversified investment portfolio. But don't make the mistake of thinking fixed interest means risk free. Here are two risks to watch.
By James Dunn
It’s the battle of the big airlines – Qantas and Virgin Australia. But should you choose either of these stocks for your SMSF portfolio?
George Boubouras: Why investors need to hold Global Equities
Gavin Madson: Sydney Airport inflation linked bond recommended
Andrew Bloore: Proportional drawdown of superannuation benefits
By Chris Gray
Cash-flow positive property means your SMSF benefits from direct income from day one. But are they all they’re cracked up to be?
With fiscal cliff concerns prevailing and markets heading lower, how long until it’s all under control and stocks head higher again?
Rudi Filapek-Vandyck: The Broker Wrap: Seven West Media and Caltex get upgrades
Lance Lai: Real test is on after getting the retracement we had to have
The market's nerves are being tested and we're going to be on shaky ground until the US safely avoids the fiscal cliff. Should you be buying stocks now?
Santa normally brings the stock markets a nice rally for Christmas, but there are some grinches about that could steal this year's festive gains.
Rudi Filapek-Vandyck: The broker wrap: Upgrades for Alumina and Myer
